Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
about
Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficitsClinical outcome measures in juvenile idiopathic arthritisWhat does an adult rheumatologist need to know about juvenile idiopathic arthritis?Advances in the treatment of polyarticular juvenile idiopathic arthritisSerum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study.Juvenile Idiopathic ArthritisGenomic characterization of remission in juvenile idiopathic arthritis.A diagnostic approach for defining idiopathic remitting diabetes: a retrospective cohort study.Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression.Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records.The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetRemission in rheumatoid arthritis.Methods of formal consensus in classification/diagnostic criteria and guideline development.Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging?Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritisRNA sequencing from human neutrophils reveals distinct transcriptional differences associated with chronic inflammatory states.Disease-Associated Single-Nucleotide Polymorphisms From Noncoding Regions in Juvenile Idiopathic Arthritis Are Located Within or Adjacent to Functional Genomic Elements of Human Neutrophils and CD4+ T Cells.Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.Inactive disease and remission in childhood-onset systemic lupus erythematosusBiological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent.Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis.Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.Youth report of healthcare transition counseling and autonomy support from their rheumatologist.Using Patient-Reported Outcome Measures to Capture the Patient's Voice in Research and Care of Juvenile Idiopathic Arthritis.Limits of Peripheral Blood Mononuclear Cells for Gene Expression-Based Biomarkers in Juvenile Idiopathic Arthritis.Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritisThe meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease statesCurrent developments in the use of biomarkers for juvenile idiopathic arthritis.Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration.Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy.Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumatic drug withdrawal: why we need a consensus.Optimization of pediatric rheumatology therapeutics.Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?How common is remission in juvenile idiopathic arthritis: A systematic review.Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes.High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects.
P2860
Q24653333-39360A53-1AA7-437C-AE38-9027836416FBQ26752701-AFB1AD71-4447-4BE9-882E-7BE5C16F6D89Q26995394-F986915C-7BBF-4B3D-8C28-C8F81F51A810Q27001017-05B88324-5B12-4F3F-AF0C-314674BD3630Q30481097-5459A55F-C34C-42AF-855E-1DDE05AC2A48Q33572045-4CB3C3A3-9351-4EE5-BD0B-ED5C43EF6E20Q33775236-C0CBDD79-50B5-420C-8BD0-33F5BC58DB62Q33783221-1EFC968B-BA02-4478-898E-EDB0FB897492Q33815056-2AC247B1-7073-43EE-B52A-A3CECC054258Q33872872-67717B30-B1BA-47F4-B018-7EFD68263373Q33940062-5B5F9E3A-349B-4283-9EA9-DACF52AD6BA7Q34081946-343DB963-47A9-45F4-9A65-45F1523D4B41Q35091202-300E0F7A-A6EB-4025-8B4E-2F3FD62D1540Q35209487-70554252-A118-46FF-BECC-DF4187CA10E5Q35431243-3E53F5B3-A5FE-434C-81B2-805F79A685C0Q35743755-A5389B8D-F332-4160-8A5C-8CC5A7B6A695Q35756615-A3F6EEE5-BDBE-483C-A704-9AFCB15F476EQ35797997-983EE99A-F78A-4838-91AB-D4BB297E2313Q35870808-BA8ED355-60AD-4DA7-81BB-493D91AC09CDQ35911531-213176E5-39F5-4394-A507-3754F555C20AQ36183846-17799B40-57E0-4EBA-823F-4FEF2E611D07Q36203332-29C6D324-C96A-48A9-AF1A-BC8DB3BD812CQ36453159-1C7EFBD7-60B7-490C-9DF1-2FC2587BD534Q36552255-DE3C65F9-688C-4141-87C7-8ABF2A087BEDQ36860571-26A0FA7E-A1A1-448B-98DB-567B7F65EE4BQ37072649-1FDBFEE3-CCAF-41DF-8DD5-7D529778AB7AQ37207120-9740825D-FF04-4C68-9359-71A096FB1378Q37378370-BD0F111F-6129-4212-8623-93CB9E80721CQ37595918-7C4A0D3D-D480-4E58-BD30-8F85F617A032Q37747685-82C6BF8A-0744-4E11-8A64-7001D0C2349EQ37845682-83B268D4-8C89-434F-8320-B2A3732C9579Q37866288-D11A5778-7D3A-4E2D-A464-3006061DC231Q37965666-30656212-82CD-40E2-9F3F-5642C05802F4Q37991520-5427262D-C84D-4FC5-99F1-E83122C20B11Q38223059-7E9B90AD-3DD1-4420-97B6-28513D80E955Q38238947-41CA8B64-E09C-4B73-9488-E6D861231728Q38720413-0ABA3815-6D59-49E9-B7CC-62228387DDC7Q38765960-DC484CBA-3B88-4A8F-8268-0660B48B1005Q38913955-B11FE0DD-29DC-4390-936D-31DCF273C4E2Q38927231-E2ABFBD6-F471-4CE4-B0A3-6D0AC63B4967
P2860
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
@ast
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
@en
type
label
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
@ast
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
@en
prefLabel
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
@ast
Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
@en
P2093
P356
P1476
Patterns of clinical remission in select categories of juvenile idiopathic arthritis
@en
P2093
Carol A Wallace
Edward H Giannini
Marcia Bandeira
P304
P356
10.1002/ART.21389
P577
2005-11-01T00:00:00Z